MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
78.01
-1.57
-1.97%
After Hours: 78.01 0 0.00% 16:45 05/15 EDT
OPEN
79.28
PREV CLOSE
79.58
HIGH
80.00
LOW
76.67
VOLUME
324.96K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
56.71
MARKET CAP
1.77B
P/E (TTM)
19.90
1D
5D
1M
3M
1Y
5Y
1D
Emmaus Life Sciences Q1 FY26 net loss widens to $3.3 million; net revenues fall 18% to $2 million
PUBT · 13h ago
Top Executives Quietly Unload a Wave of ANI Pharmaceuticals Shares
TipRanks · 2d ago
ANI Pharma director Patrick D. Walsh disposes common shares worth $1.13 million
PUBT · 2d ago
ANI Pharma CEO Nikhil Lalwani sells 55,000 shares for $4.27 million
PUBT · 2d ago
ANI SVP Thomas Rowland disposes 459 shares for $36,357.39
PUBT · 2d ago
ANI Pharma General Counsel Meredith Cook sells 500 shares worth $39,080
PUBT · 2d ago
ANI Pharmaceuticals Updates Investor Presentation, Highlights Non-GAAP Metrics
TipRanks · 2d ago
ANI Pharma releases corporate presentation outlining rare-disease shift, 2026 revenue outlook $1.1-$1.14 billion
PUBT · 2d ago
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units, Rare Disease and Brands. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel and ILUVIEN. The Brands unit includes a portfolio of over 20 branded products that are principally sold in genericized markets. Its Generics and Other segment consists of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.